IP Library Assignment 037072/0984
Patent Assignment
Reel/Frame 037072/0984

Patent Security Agreement

Recorded: 2015-11-09 Pages: 7
Assignor
ACCERA, INC.
Executed: 2015-10-30
Assignee
NESTLE HEALTH SCIENCE US HOLDINGS, INC., AS COLLATERAL AGENT
900 LONG RIDGE ROAD, BUILDING 2, STAMFORD, CONNECTICUT, 06902
Covered Properties (2)
Use of Medium Chain Triglycerides for the Treatment and Prevention of Alzheimer's Disease and Other Diseases Resulting from Reduced Neuronal Metabolism II
Patent: 9,603,823 →
Application: 13/859,608 →
Publication: US 2013/0225682
Use of Ketogenic Compounds for Treatment of Age-Associated Memory Impairment
Application: 14/269,453 →
Publication: US 2014/0256808
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 18, 2013
From: HENDERSON, SAMUEL T.
To: ACCERA, INC.
Reel/Frame 030242/0673 →
Assignment of Assignor's Interest Apr 18, 2013
From: HENDERSON, SAMUEL T.
To: ACCERA, INC.
Reel/Frame 030242/0796 →
Assignment of Assignor's Interest Oct 29, 2014
From: HENDERSON, SAMUEL T.
To: ACCERA, INC.
Reel/Frame 034061/0401 →
Change of Name Aug 26, 2020
From: ACCERA, INC.
To: CERECIN INC.
Reel/Frame 053605/0604 →
Release of Security Interest Feb 10, 2025
From: NESTLÉ HEALTH SCIENCE US HOLDINGS, INC.
To: CERECIN INC.
Reel/Frame 070168/0946 →